United States
Germany
Japan
United Kingdom
China
TGF beta 1 (TGFB1) mouse monoclonal antibody, clone 8C4, Azide Free
| Applications | ELISA, FN, IHC |
| Reactivities | Human |
Products
TGFB1 - human gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 GFP-puro donor, 1 scramble control |
| Donor DNA | GFP-puro |
Rabbit polyclonal TGF beta 1 antibody
| Applications | WB |
| Reactivities | Human |
Rabbit Polyclonal Anti-TGF beta1 Antibody
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
TGFB1 - human gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 Luciferase-Puro donor, 1 scramble control |
| Donor DNA | Luciferase-Puro |
TGFB1 - human gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 RFP-BSD donor, 1 scramble control |
| Donor DNA | RFP-BSD |
TGFB1 - human gene knockout kit via CRISPR, HDR mediated
| Format | 2 gRNA vectors, 1 mBFP-Neo donor, 1 scramble control |
| Donor DNA | mBFP-Neo |
TGFB1 MS Standard C13 and N15-labeled recombinant protein (NP_000651)
| Tag | C-Myc/DDK |
| Expression Host | HEK293 |
3' UTR clone of transforming growth factor beta 1 (TGFB1) for miRNA target validation
| Vector | pMirTarget |
| Species | Human |
| Transfection Reporter | RFP |
| Assay Reporter | Luciferase |
Biotinylated Human TGF-beta 1 (N-Avi)
| Tag | N-Avi |
Rabbit anti TGF beta 1 Polyclonal Antibody
| Reactivities | Human |
Rabbit anti TGF beta Polyclonal Antibody
| Reactivities | Human, Mouse, Rat |
Recombinant Human LAP (TGF-beta 1)
Recombinant Human Transforming Growth Factor β-1/TGFB1 (N-8His)
| Tag | N-His |
TGFB1 mouse monoclonal antibody, clone OTI2B5 (formerly 2B5)
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Vectors
Conjugates
Isotypes
Clonalities
Mutants
Assay Types
QC Levels
Families
Pathways
- Cell cycle (42)
- Chronic myeloid leukemia (42)
- Colorectal cancer (42)
- Cytokine-cytokine receptor interaction (42)
- Dilated cardiomyopathy (42)
- Hypertrophic cardiomyopathy (HCM) (42)
- MAPK signaling pathway (42)
- Pancreatic cancer (42)
- Pathways in cancer (42)
- Renal cell carcinoma (42)
- TGF-beta signaling pathway (42)
